SPRINTEC Drug Patent Profile
✉ Email this page to a colleague
When do Sprintec patents expire, and what generic alternatives are available?
Sprintec is a drug marketed by Barr and is included in one NDA.
The generic ingredient in SPRINTEC is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SPRINTEC?
- What are the global sales for SPRINTEC?
- What is Average Wholesale Price for SPRINTEC?
Summary for SPRINTEC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Drug Prices: | Drug price information for SPRINTEC |
| Drug Sales Revenues: | Drug sales revenues for SPRINTEC |
| DailyMed Link: | SPRINTEC at DailyMed |
Recent Clinical Trials for SPRINTEC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Society of Family Planning | Phase 1 |
| University of Pennsylvania | Phase 1 |
| American Heart Association | Phase 4 |
US Patents and Regulatory Information for SPRINTEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | SPRINTEC | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 075804-001 | Sep 25, 2002 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
